Near-term headwinds persist, but biologics scale-up and ADC push set the stage for a FY28 comeback ...

Oncologic drug development needs to place a greater focus on the patient, according to a commentary in the current issue of the New England Journal of Medicine. Even though the US Food and Drug ...

• Existing uses and current efficiencies: Artificial intelligence, including generative AI, is enhancing efficiency and effectiveness in trial design, patient recruitment and drug manufacturing, and ...

Sriram Krishnan, Ph.D., Chief Product Officer at Target RWE; 20+ years building health tech, inventor on 28 patents, author of 30+ papers. As the chief product officer at Target RWE, a health ...

In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...